IPO - Cara Therapeutics, Inc.

Form Type: S-1

Filing Date: 2025-05-30

Corporate Action: Ipo

Type: New

Accession Number: 000110465925054853

Filing Summary: Tvardi Therapeutics, Inc. has filed a registration statement on Form S-1 in connection with its initial public offering (IPO). The company seeks to raise capital through the sale of common stock to the public market. Key information in the filing includes financial statements, management analysis, a description of the business, and the intended use of proceeds from the offering, which will primarily support ongoing clinical trials and operational expansion. The filing date for this document is set for May 30, 2025, indicating the company’s preparation for a significant transition to public company status.